Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05334069 · ClinicalTrials.gov registry record

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A clinical trial of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, sponsored by Alliance for Clinical Trials in Oncology.

Recruiting
Registry status
2,000
Enrollment target
20
Study locations

NCT05334069: Recruiting study of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, sponsored by Alliance for Clinical Trials in Oncology.

NCT05334069 is a study of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 2,000 participants, above the 109-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1735% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05334069, a study of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.

RECRUITING
Registry status
2,000 participants
Enrollment target
20
Study locations

Study Summary

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Primary Outcome

Diagnostic ability will be assessed across the entire cohort of 2000 subjects by estimating the sensitivity and specificity with 95% confidence intervals.

Conditions Studied

Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Gastroesophageal Junction Adenocarcinoma Chronic Myeloid Leukemia Head and Neck Carcinoma Ann Arbor Stage I Lymphoma Ann Arbor Stage II Lymphoma Ann Arbor Stage III Lymphoma Ann Arbor Stage IV Lymphoma

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Questionnaire Administration

Study Locations (20)

Alaska

  • Anchorage Associates in Radiation Medicine - Anchorage
  • Anchorage Radiation Therapy Center - Anchorage
  • Alaska Breast Care and Surgery LLC - Anchorage
  • Alaska Oncology and Hematology LLC - Anchorage
  • Alaska Women's Cancer Care - Anchorage
  • Anchorage Oncology Centre - Anchorage
  • Katmai Oncology Group - Anchorage
  • Providence Alaska Medical Center - Anchorage
  • Fairbanks Memorial Hospital - Fairbanks

California

  • Mission Hope Medical Oncology - Arroyo Grande - Arroyo Grande
  • PCR Oncology - Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital - Bakersfield
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center - Burbank
  • Mercy Cancer Center - Carmichael - Carmichael
  • Mercy San Juan Medical Center - Carmichael
  • John Muir Medical Center-Concord - Concord

Arizona

  • Kingman Regional Medical Center - Kingman
  • Cancer Center at Saint Joseph's - Phoenix

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith
  • CARTI Cancer Center - Little Rock

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2022-08-18
Est. Completion 2027-02-28
Alliance for Clinical Trials in Oncology

446 total trials

What NCT05334069 shows while recruiting

NCT05334069 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 109-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1735% higher).

The record links to 10 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT05334069 names 20 study sites across 4 states, led by Alaska, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT05334069 about?

NCT05334069 is a clinical study titled "Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection". This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early...

What is the current status of trial NCT05334069?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-08-18. Estimated completion is 2027-02-28.

What conditions does trial NCT05334069 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Gastroesophageal Junction Adenocarcinoma, Chronic Myeloid Leukemia.

What interventions are being tested in trial NCT05334069?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT05334069?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05334069 being conducted?

This trial has 20 study locations across Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05334069's enrollment target sits among peer trials

2,000 1st of 306 the highest of 306 other Acute Myeloid Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Myeloid Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05334069

Source: ClinicalTrials.gov NCT05334069, the US trial registry maintained by the National Library of Medicine. NCT05334069 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.